Bausch Health Companies Inc. SEC filings BHC
Bausch Health Companies Inc. has 1,004 filings in SEC EDGAR's recent list, going back to May 4, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 19, 2026 |
| DEF 14A | Proxy statement | Aug 27, 2025 | Oct 7, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 13, 2025 | Oct 7, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEFA14A | Additional proxy material | Apr 2, 2025 | — |
| DEF 14A | Proxy statement | Apr 2, 2025 | May 13, 2025 |
| DEFA14A | Additional proxy material | Apr 4, 2024 | — |
| DEF 14A | Proxy statement | Apr 4, 2024 | May 14, 2024 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | — |
| DEFA14A | Additional proxy material | Jun 15, 2022 | — |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 21, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2021 | — |
| DEFA14A | Additional proxy material | Mar 18, 2021 | — |
| DEF 14A | Proxy statement | Mar 18, 2021 | Apr 27, 2021 |
| DEFA14A | Additional proxy material | Apr 10, 2020 | — |
| DEFA14A | Additional proxy material | Apr 2, 2020 | — |
| DEFA14A | Additional proxy material | Mar 16, 2020 | — |
| DEF 14A | Proxy statement | Mar 16, 2020 | Apr 28, 2020 |
| DEFA14A | Additional proxy material | Mar 29, 2019 | — |
| DEFA14A | Additional proxy material | Mar 18, 2019 | — |
| DEF 14A | Proxy statement | Mar 18, 2019 | Apr 30, 2019 |
| DEFA14A | Additional proxy material | Mar 30, 2018 | — |
| DEFA14A | Additional proxy material | Mar 21, 2018 | — |
| DEF 14A | Proxy statement | Mar 21, 2018 | Apr 30, 2018 |
| DEFA14A | Additional proxy material | Apr 3, 2017 | — |
| DEF 14A | Proxy statement | Mar 23, 2017 | May 2, 2017 |
| DEFA14A | Additional proxy material | May 24, 2016 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BHC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NJ
- Headquarters
- Quebec, Quebec, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 885590
- Former names
- Valeant Pharmaceuticals International, Inc. (until Jul 3, 2018); BIOVAIL Corp (until Sep 27, 2010); BIOVAIL CORP INTERNATIONAL (until Apr 7, 2010); BIOVAIL CORPORATION INTERNATIONAL (until Jan 5, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.